USAQ (QHSLab) Cyclically Adjusted PB Ratio: (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

USAQ QHSLab Inc USAQ
50 GF Score
Price $0.30
GF Value $0.18
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is QHSLab Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


QHSLab  (OTCPK:USAQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


QHSLab Cyclically Adjusted PB Ratio Related Terms


QHSLab Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for QHSLab's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QHSLab Cyclically Adjusted PB Ratio Chart

QHSLab Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

QHSLab Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

USAQ vs ITOC, ALURD, INBS: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, QHSLab's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QHSLab Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where QHSLab's Cyclically Adjusted PB Ratio falls into.


USAQ
50GF Score
QHSLab Inc USAQ
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QHSLab Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

QHSLab's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, QHSLab's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.104/333.9520*333.9520
=0.104

Current CPI (Jun. 2026) = 333.9520.

QHSLab Quarterly Data

Book Value per Share CPI Adj_Book
201609 -0.134 241.428 -0.185
201612 -0.135 241.432 -0.187
201703 -0.135 243.801 -0.185
201706 -0.136 244.955 -0.185
201709 -0.137 246.819 -0.185
201712 -0.138 246.524 -0.187
201803 -0.139 249.554 -0.186
201806 -0.145 251.989 -0.192
201809 -0.147 252.439 -0.194
201812 -0.149 251.233 -0.198
201903 -0.152 254.202 -0.200
201906 -0.154 256.143 -0.201
201909 -0.081 256.759 -0.105
201912 -0.075 256.974 -0.097
202003 -0.088 258.115 -0.114
202006 -0.086 257.797 -0.111
202009 -0.091 260.280 -0.117
202012 -0.093 260.474 -0.119
202103 -0.060 264.877 -0.076
202106 0.065 271.696 0.080
202109 0.067 274.310 0.082
202112 0.094 278.802 0.113
202203 0.077 287.504 0.089
202206 0.046 296.311 0.052
202209 0.031 296.808 0.035
202212 0.008 296.797 0.009
202303 -0.012 301.836 -0.013
202306 -0.023 305.109 -0.025
202309 -0.032 307.789 -0.035
202312 -0.039 306.746 -0.042
202403 -0.037 312.332 -0.040
202406 -0.037 314.175 -0.039
202409 -0.032 315.301 -0.034
202412 -0.056 315.605 -0.059
202503 -0.052 319.799 -0.054
202506 -0.057 322.561 -0.059
202509 -0.054 324.800 -0.056
202512 0.108 324.054 0.111
202603 0.101 330.213 0.102
202606 0.104 333.952 0.104

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is QHSLab (USAQ) Overvalued in 2026?

Based on GuruFocus' analysis, QHSLab stock appears to be overvalued. The current stock price of $0.30 is trading 66.7% above its estimated GF Value™ of $0.18. GuruFocus considers QHSLab to be Significantly Overvalued.

Key valuation signals for USAQ:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $0.18 vs. price of $0.30 (66.7% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the USAQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


QHSLab Business Description

Address 901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
50GF Score

Get the complete analysis for USAQ

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30
Price
$0.18
GF Value